Global  

Study focuses on new tool that enables easy, effective disease tracking

Video Credit: ANI - Duration: 01:00s - Published
Study focuses on new tool that enables easy, effective disease tracking

Study focuses on new tool that enables easy, effective disease tracking

A new open source, a cloud-based tool called IDseq makes it possible to rapidly detect, identify, and track emerging pathogens such as SARS-CoV-2.

This tool can identify pathogens before there is an available complete genome sequence; thus, it can be used for current infectious disease outbreaks and also for emerging ones.

This will substantially aid in preventing future pandemics.

The study was published in the journalGigaScience.

The coronavirus pandemic demonstrates the importance of global infectious disease monitoring.

Finding the cause of an infectious disease outbreak is challenging, especially if it stems from a previously unknown pathogen.

IDseq, an open-source, cloud-based metagenomic analysis platform, identifies both novel and existing disease-causing pathogens from a given sample - be it a human, animal, or parasite - to provide an actionable report of what is happening on the ground in labs and clinics anywhere in the world.

The new user-friendly IDseq software is open source and freely available to the global health community, reducing the barrier of entry to metagenomics.


You Might Like


💡 One News Page Knowledge: Other News Mentions

Severe acute respiratory syndrome coronavirus 2 Severe acute respiratory syndrome coronavirus 2 Virus strain that causes coronavirus disease 2019 (COVID-19)

Routine testing for COVID-19 can make surgery safer: Study [Video]

Routine testing for COVID-19 can make surgery safer: Study

Routine testing patients for COVID-19 before major surgery could reduce the risk of respiratory complications and save lives, a new study revealed. Researchers working together around the world found that using a nasal swab test to confirm that asymptomatic patient was not infected with SARS-CoV-2 was associated with a lower rate of postoperative complications. The main benefit was seen before major surgery and areas with a higher rate of COVID-19. Swab testing gave an opportunity for surgeons to identify asymptomatic infected patients and postpone their operation, avoiding the severe risk of COVID-19 complications after surgery. Routine testing also helped to prevent cross-infection from patients with no symptoms to other elective surgical patients upon admission to hospital. The COVIDSurg toolkit will support individual hospitals, regions, and countries during a major global reorganisation of surgical services during the pandemic and beyond.

Credit: ANI    Duration: 01:21Published
Study suggests age does not contribute to COVID-19 susceptibility [Video]

Study suggests age does not contribute to COVID-19 susceptibility

Scientists have estimated that the age of an individual does not indicate how likely they are to be infected by SARS-CoV-2. However, the development of symptoms, the progression of the disease, and mortality are age-dependent. There have been a large number of deaths due to the ongoing COVID-19 pandemic, and it has been shown that elderly individuals disproportionately develop severe symptoms and show higher mortality. A team of scientists, including Associate Professor Ryosuke Omori from the Research Center for Zoonoses Control at Hokkaido University, have modelled available data from Japan, Spain and Italy to show that susceptibility to COVID-19 is independent of age, while the occurrence of symptomatic COVID-19, severity and mortality is likely dependent on age. Their results were published in the journal Scientific Reports on October 6, 2020.

Credit: ANI    Duration: 01:30Published

Related news from verified sources


Related videos from verified sources

Astra Zeneca's 'Oxford' COVID-19 Vaccine Found Safe, Especially For Elderly [Video]

Astra Zeneca's 'Oxford' COVID-19 Vaccine Found Safe, Especially For Elderly

A new study reveals a COVID-19 vaccine under development in England safely promotes an immune response against the virus. According to UPI, the vaccine is in Phase 2 of clinical trials with Astra..

Credit: Wochit     Duration: 00:37Published
A change of heart- new drug for HCM reduces heart mass [Video]

A change of heart- new drug for HCM reduces heart mass

For the first time, medication has impacted heart muscle thickness and function for patients with the most common inherited heart condition, rather than simply addressing their symptoms. "This is the..

Credit: ANI     Duration: 01:22Published
Covid-19 vaccine findings 'even better than we expected' [Video]

Covid-19 vaccine findings 'even better than we expected'

Professor Danny Altmann from Imperial College London has said the positive studies showing a 90% effective Covid-19 vaccine is "terribly good news...even better than we expected". Pharmaceutical firm..

Credit: ODN     Duration: 00:31Published